These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7655779)

  • 1. A randomized trial of the effects of pharmacist intervention on the cost of antiemetic therapy with ondansetron.
    Dranitsaris G; Warr D; Puodziunas A
    Support Care Cancer; 1995 May; 3(3):183-9. PubMed ID: 7655779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of treating and preventing nausea and vomiting in patients receiving chemotherapy.
    Stewart DJ; Dahrouge S; Coyle D; Evans WK
    J Clin Oncol; 1999 Jan; 17(1):344-51. PubMed ID: 10458253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing evidence based antiemetic guidelines in the oncology setting: results of a 4-month prospective intervention study.
    Dranitsaris G; Leung P; Warr D
    Support Care Cancer; 2001 Nov; 9(8):611-8. PubMed ID: 11762972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in the use of ondansetron as an antiemetic drug in children treated with chemotherapy.
    Ninane J; Ozkaynak MF; Kurtin P; Siegel SE
    Med Pediatr Oncol; 1995 Jul; 25(1):33-7. PubMed ID: 7753000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of antiemetic therapy for ambulatory surgery.
    Watcha MF; Smith I
    J Clin Anesth; 1994; 6(5):370-7. PubMed ID: 7986508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
    Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The real costs of emesis--an economic analysis of ondansetron vs. metoclopramide in controlling emesis in patients receiving chemotherapy for cancer.
    Cunningham D; Gore M; Davidson N; Miocevich M; Manchanda M; Wells N
    Eur J Cancer; 1993; 29A(3):303-6. PubMed ID: 8398322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a phase III trial by the National Cancer Institute of Canada Clinical Trials Group.
    Kaizer L; Warr D; Hoskins P; Latreille J; Lofters W; Yau J; Palmer M; Zee B; Levy M; Pater J
    J Clin Oncol; 1994 May; 12(5):1050-7. PubMed ID: 8164029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter evaluation of ondansetron use in hospitalized oncology patients.
    Peters MD; Long KS; Patel HS; Reitz JA; Jessen LM; Emhart GC
    Am J Hosp Pharm; 1993 Jun; 50(6):1164-70. PubMed ID: 8517455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
    Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
    Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ondansetron and tropisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
    Stiakaki E; Savvas S; Lydaki E; Bolonaki I; Kouvidi E; Dimitriou H; Kambourakis A; Kalmanti M
    Pediatr Hematol Oncol; 1999; 16(2):101-8. PubMed ID: 10100270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone.
    Lindley C; Goodin S; McCune J; Kane M; Amamoo MA; Shord S; Pham T; Yowell S; Laliberte K; Schell M; Bernard S; Socinski MA
    Am J Clin Oncol; 2005 Jun; 28(3):270-6. PubMed ID: 15923800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ondansetron and dexamethasone versus standard combination antiemetic therapy. A randomized trial for the prevention of acute and delayed emesis induced by cyclophosphamide-doxorubicin chemotherapy and maintenance of antiemetic effect at subsequent courses.
    Campora E; Giudici S; Merlini L; Rubagotti A; Rosso R
    Am J Clin Oncol; 1994 Dec; 17(6):522-6. PubMed ID: 7977174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial.
    Gebbia V; Cannata G; Testa A; Curto G; Valenza R; Cipolla C; Latteri MA; Gebbia N
    Cancer; 1994 Oct; 74(7):1945-52. PubMed ID: 8082100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a compassionate-use program using intravenous ondansetron to prevent nausea and vomiting in patients receiving emetogenic cancer chemotherapy.
    Berry WR; House KW; Lee JT; Plagge PB; Meshad MW; Grapski R
    Semin Oncol; 1992 Dec; 19(6 Suppl 15):33-7. PubMed ID: 1485180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ondansetron versus granisetron in the prevention of chemotherapy induced nausea and vomiting in children with acute lymphoblastic leukemia.
    Siddique R; Hafiz MG; Rokeya B; Jamal CY; Islam A
    Mymensingh Med J; 2011 Oct; 20(4):680-8. PubMed ID: 22081189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter postmarketing surveillance of ondansetron therapy in pediatric patients.
    McQueen KD; Milton JD
    Ann Pharmacother; 1994 Jan; 28(1):85-92. PubMed ID: 8123969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ondansetron with customary treatment in the prophylaxis of nausea and emesis induced by non-cisplatin containing chemotherapy.
    Jantunen IT; Flander MK; Heikkinen MI; Kuoppala TA; Teerenhovi L; Kataja VV
    Acta Oncol; 1993; 32(4):413-5. PubMed ID: 8369129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is ondansetron cost effective?
    Bonneterre J
    Pharmacoeconomics; 1994 Dec; 6(6):581-3. PubMed ID: 10155287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy.
    Italian Group for Antiemetic Research
    N Engl J Med; 2000 May; 342(21):1554-9. PubMed ID: 10824073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.